1762192209 unnamed file.jpg

Profit paradox: What’s distorting IPO valuations? Zerodha’s Nithin Kamath shares striking insights

Nithin Kamath (File photo) For anyone investing in IPOs or tracking startup stocks, Zerodha co-founder Nithin Kamath has offered a striking explanation for why many venture-backed firms prefer losses over profits — and how India’s tax structure may be quietly driving that behaviour.In a detailed post on X, Kamath pointed out that taking money out…

Read More
1762190795 unnamed file.jpg

Gold slides Rs 11,000 from peak as dollar strengthens: Silver outperforms with festive boost; should you buy the dip or wait for more correction?

Gold prices slipped close to a three-week low on Monday, dragged down by a stronger dollar and easing trade tensions between the US and China. On the Multi Commodity Exchange (MCX), gold opened weaker at Rs 1,21,284 per 10 grams, down Rs 224 or 0.18%, while silver prices gained Rs 1,087 or 0.73% to Rs…

Read More
1762187934 unnamed file.jpg

Bharti Airtel Q2 results: Profit more than doubles to Rs 8,651 crore; ARPU outpaces Jio amid premium user push

Bharti Airtel on Monday reported that its consolidated net profit more than doubled year-on-year to Rs 8,651 crore for the September quarter of FY26, driven by strong growth in high-value smartphone users and post-paid connections.The telecom major had posted a profit of Rs 4,153.4 crore in the same quarter a year ago. Its Africa arm…

Read More
1762186459 unnamed file.jpg

Bharat Biotech forays into CRDMO space with new cell & gene therapies arm Nucelion Therapeutics

HYDERABAD: Vaccine maker Bharat Biotech is foraying into the contract research development and manufacturing organisation (CDRMO) space with the setting up of a new wholly-owned subsidiary, Nucelion Therapeutics Pvt Ltd, that is focused on cell and gene therapies (CGT).Announcing its entry into this high growth CRDMO segment, Bharat Biotech said the new entity will support…

Read More
1762185045 unnamed file.jpg

OpenAI-Amazon cloud deal: OpenAI seals $38 billion deal with Amazon for AI computing power; Microsoft exclusivity ends

OpenAI has signed a $38 billion agreement with Amazon to run its artificial intelligence systems on Amazon Web Services (AWS), gaining access to “hundreds of thousands” of Nvidia’s AI chips through the deal announced Monday, AP reported.The partnership comes just days after OpenAI revised its arrangement with longtime backer Microsoft, which will no longer remain…

Read More
1762183392 unnamed file.jpg

US markets today: Nvidia and AI stocks lift Wall Street even as most shares decline; Dow dips, S&P 500 nears record high

Wall Street traded mixed on Monday, with major technology stocks once again steering the market higher even as most other sectors struggled. The S&P 500 added 0.4% in early trading, inching close to its record high set last week. The tech-heavy Nasdaq composite climbed 0.9%, while the Dow Jones Industrial Average slipped 34 points, or…

Read More
1762178873 unnamed file.jpg

Vodafone Idea rally: Shares lock in 10% upper circuit after SC clarity on AGR dues; is this the relief investors were waiting for?

Vodafone Idea shares surged nearly 10% on Monday to hit the upper circuit at Rs 9.60 on the BSE, after the Supreme Court provided crucial clarity on the long-pending issue of Adjusted Gross Revenue (AGR) dues. The development eased investor concerns over the telecom firm’s massive liabilities and lifted sentiment around the stock.The apex court…

Read More
1762177441 unnamed file.jpg

Consumer healthcare mega merger: Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion cash and stock deal; $1.9 billion cost savings targeted post-merger

Kimberly-Clark is set to acquire Tylenol maker Kenvue in a cash-and-stock transaction valued at approximately $48.7 billion, creating one of the world’s largest consumer health goods companies, AP reported.Under the terms of the agreement, Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held at closing. Based…

Read More
1762176007 unnamed file.jpg

Microsoft-IREN deal: Tech giant inks $9.7 billion AI cloud pact for Nvidia chips; aims to bolster data centre capacity amid soaring AI demand

Microsoft has entered into a $9.7 billion cloud services agreement with Australian artificial intelligence infrastructure provider IREN, a deal that will give the tech major access to Nvidia chips as it scales its AI and cloud operations, AP reported.The five-year agreement includes a 20% prepayment and is aimed at supporting Microsoft’s efforts to meet the…

Read More